Although there is evidence of deal-making...China and Malaysia... (where is that South African deal?), we still don’t know if this dog will hunt. We’ve had some internet interviews reporting that GNBT are ‘confident’ in the efficacy of the peptides that have been in investigation...since June. But nothing concrete. Nothing finalized. No end point. No press release with results. No green light from the US FDA for GNBT to push forward into human trials. No anything.
And although there are some who believe that the share price is being intentionally depressed, I think that until the phase 2/3 trials commence, that the share price will sit where it is, and that the spin out of NGIO will always be tomorrow, until the human trials are going forward. How could an uptick in the share price be justified otherwise?
The vigil continues. Do we have a new Pope yet?